Yahoo
HKSE - Delayed Quote HKD

YSB Inc. (9885.HK)

3.410 -0.030 (-0.87%)
At close: 4:08:14 PM GMT+8
Chart Range Bar
Loading chart for 9885.HK
  • Previous Close 3.440
  • Open 3.395
  • Bid 3.380 x --
  • Ask 3.410 x --
  • Day's Range 3.355 - 3.530
  • 52 Week Range 2.960 - 9.800
  • Volume 641,800
  • Avg. Volume 594,715
  • Market Cap (intraday) 2.331B
  • Beta (5Y Monthly) 0.44
  • PE Ratio (TTM) 11.37
  • EPS (TTM) 0.300
  • Earnings Date --
  • Forward Dividend & Yield 0.13 (3.63%)
  • Ex-Dividend Date May 26, 2026
  • 1y Target Est --

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. In addition, the company engages in the wholesale and retail of pharmaceutical and healthcare products. Further, it provides medical testing services; logistics services; and ClouDiagnos. YSB Inc. was founded in 2015 and is headquartered in Guangzhou, China.

www.ysbang.cn

6,795

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

9885.HK
34.50%
HANG SENG INDEX (^HSI)
8.73%

1-Year Return

9885.HK
61.32%
HANG SENG INDEX (^HSI)
9.70%

3-Year Return

9885.HK
81.33%
HANG SENG INDEX (^HSI)
35.77%

5-Year Return

9885.HK
85.21%
HANG SENG INDEX (^HSI)
6.80%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.87%

  • Return on Assets (ttm)

    0.90%

  • Return on Equity (ttm)

    7.86%

  • Revenue (ttm)

    21.41B

  • Net Income Avi to Common (ttm)

    185.68M

  • Diluted EPS (ttm)

    0.300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.8B

  • Total Debt/Equity (mrq)

    12.70%

  • Levered Free Cash Flow (ttm)

    358.47M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: